The relation of leptin and adiponectin with breast density among premenopausal women

European Journal of Cancer Prevention

Volumn 19, Issue 1, 2010, Pages 55-60

  Maskarinec, Gertraud ^a   Woolcott, Christy ^a   Steude, Jana S ^a   Franke, Adrian A ^a   Cooney, Robert V ^a  

^a UNIVERSITY OF HAWAII CANCER CENTER   (United States)

Author keywords

Adiponectin; Adiposity; Breast cancer risk; Ethnicity; Leptin; Mammographic density

Indexed keywords

ADIPONECTIN; LEPTIN;

ADULT; ARTICLE; ASIAN; BODY MASS; BREAST; BREAST CANCER; CANCER RISK; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; OBESITY; PREMENOPAUSE; PRIORITY JOURNAL; RISK ASSESSMENT;

ADIPONECTIN; ADULT; BODY COMPOSITION; BODY MASS INDEX; BREAST; BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; HUMANS; LEPTIN; MAMMOGRAPHY; MIDDLE AGED; PREMENOPAUSE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS;

EID: 75149144405     PISSN: 09598278     EISSN: None     Source Type: Journal    
DOI: 10.1097/CEJ.0b013e328333fb0e     Document Type: Article

References (33)

1. Barb D,Williams CJ, Neuwirth AK, Mantzoros CS (2007). Adiponectin in relation to malignancies: a review of existing basic research and clinical evidence. Am J Clin Nutr 86:s858-s866.
2. Boyd NF, Rommens JM, Vogt K, Lee V, Hopper JL, Yaffe MJ, et al. (2005). Mammographic breast density as an intermediate phenotype for breast cancer. Lancet Oncol 6:798-808.
3. Boyd NF, Martin LJ, Sun L, Guo H, Chiarelli A, Hislop G, et al. (2006). Body size, mammographic density, and breast cancer risk. Cancer Epidemiol Biomarkers Prev 15:2086-2092.
4. Byng JW, Boyd NF, Fishell E, Jong RA, Yaffe MJ (1994). The quantitative analysis of mammographic densities. Phys Med Biol 39:1629-1638.
5. Carmichael AR, Bates T (2004). Obesity and breast cancer: a review of the literature. Breast 13:85-92. (Pubitemid 38443602)
6. Chen DC, Chung YF, Yeh YT, Chaung HC, Kuo FC, Fu OY, et al. (2006). Serum adiponectin and leptin levels in Taiwanese breast cancer patients. Cancer Lett 237:109-114.
7. Cust AE, Stocks T, Lukanova A, Lundin E, Hallmans G, Kaaks R, et al. (2009). The influence of overweight and insulin resistance on breast cancer risk and tumour stage at diagnosis: a prospective study. Breast Cancer Res Treat 1 13:567-576.
8. Deurenberg P, Yap M, Van Staveren WA (1998). Body mass index and percent body fat: a meta analysis among different ethnic groups. Int J Obes Relat Metab Disord 22:1164-1171.
9. Falk RT, Brinton LA, Madigan MP, Potischman N, Sturgeon SR, Malone KE, et al. (2006). Interrelationships between serum leptin, IGF-1, IGFBP3, C-peptide and prolactin and breast cancer risk in young women. Breast Cancer Res Treat 98:157-165.
10. Furberg AS, Jasienska G, Bjurstam N, Torjesen PA, Emaus A, Lipson SF, et al. (2005). Metabolic and hormonal profiles: HDL cholesterol as a plausible biomarker of breast cancer risk. The Norwegian EBBA Study. Cancer Epidemiol Biomarkers Prev 14:33-40.
11. Garofalo C, Surmacz E (2006). Leptin and cancer. J Cell Physiol 207:12-22.
12. Hou WK, Xu YX, Yu T, Zhang L, Zhang WW, Fu CL, et al. (2007). Adipocytokines and breast cancer risk. Chin Med J (Engl) 120:1592-1596.
13. Hursting SD, Lashinger LM, Wheatley KW, Rogers CJ, Colbert LH, Nunez NP, et al. (2008). Reducing the weight of cancer: mechanistic targets for breaking the obesity-carcinogenesis link. Best Pract Res Clin Endocrinol Metab 22:659-669.
14. Kadowaki T, Sekikawa A, Okamura T, Takamiya T, Kashiwagi A, Zaky WR, et al. (2006). Higher levels of adiponectin in American than in Japanese men despite obesity. Metabolism 55:1561-1563.
15. Littell RC, Milliken GA, Stroup WW,Wolfinger RD (1996). SAS system for mixed models. Cary, NC: SAS Institute Inc.
16. Mantzoros CS, Bolhke K, Moschos S, Cramer DW (1999). Leptin in relation to carcinoma in situ of the breast: a study of pre-menopausal cases and controls. Int J Cancer 80:523-526.
17. Marti A, Marcos A, Martinez JA (2001). Obesity and immune function relationships. Obes Rev 2:131-140.
18. Maskarinec G, Williams AE, Carlin L (2003). Mammographic densities in a one-year isoflavone intervention. Eur J Cancer Prev 12:165-169.
19. Maskarinec G, Takata Y, Franke AA, Williams AE, Murphy SP (2004a). A 2-year soy intervention in premenopausal women does not change mammographic densities. J Nutr 134:3089-3094.
20. Maskarinec G, Franke AA, Williams AE, Hebshi S, Oshiro C, Murphy SP, et al. (2004b). Effects of a 2-year randomized soy intervention on sex hormone levels in premenopausal women. Cancer Epidemiol Biomarkers Prev 1 3:1736-1744.
21. Maskarinec G, Steude JS, Franke AA, Cooney RV (2009). Inflammatory markers in a 2-year soy intervention among premenopausal women. J Inflamm (Lond) 6 :9.
22. Neilson HK, Friedenreich CM, Brockton NT, Millikan RC (2009). Physical activity and postmenopausal breast cancer: proposed biologic mechanisms and areas for future research. Cancer Epidemiol Biomarkers Prev 18:11-27.
23. Ozet A, Arpaci F, Yilmaz MI, Ayta H, Ozturk B, Komurcu S, et al. (2001). Effects of tamoxifen on the serum leptin level in patients with breast cancer. Jpn J Clin Oncol 31:424-427.
24. Purohit A, Newman SP, Reed MJ (2002). The role of cytokines in regulating estrogen synthesis: implications for the etiology of breast cancer. Breast Cancer Res 4:65-69.
25. SAS Institute Inc. (2004). SAS OnlineDoc 9.1.2. Cary, North Carolina: SAS Institute Inc.
26. Singer JD, Willett JB (2003). Applied longitudinal data analysis: modeling change and event occurrence. Oxford: Oxford University Press.
27. Stuedal A, Ursin G, Veierod MB, Bremnes Y, Reseland JE, Drevon CA, et al. (2006). Plasma levels of leptin and mammographic density among postmenopausal women: a cross-sectional study. Breast Cancer Res 8 :R55.
28. Tamimi RM, Byrne C, Colditz GA, Hankinson SE (2007). Endogenous hormone levels, mammographic density, and subsequent risk of breast cancer in postmenopausal women. J Natl Cancer Inst 99:1178-1187.
29. Tilg H, Moschen AR (2006). Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol 6:772-783.
30. Tilg H, Wolf AM (2005). Adiponectin: a key fat-derived molecule regulating inflammation. Expert Opin Ther Targets 9:245-251.
31. Tworoger SS, Eliassen AH, Kelesidis T, Colditz GA, Willett WC, Mantzoros CS, et al. (2007). Plasma adiponectin concentrations and risk of incident breast cancer. J Clin Endocrinol Metab 92:1510-1516.
32. Wolf AM, Wolf D, Rumpold H, Enrich B, Tilg H (2004). Adiponectin induces the anti-inflammatory cytokines IL-10 and IL-1RA in human leukocytes. Biochem Biophys Res Commun 323:630-635.
33. Wu MH, Chou YC, Chou WY, Hsu GC, Chu CH, Yu CP, et al. (2009). Circulating levels of leptin, adiposity and breast cancer risk. Br J Cancer 1 00:578-582.